Literature DB >> 18083983

Use of sustained-release moxidectin to prevent eyeworm (Thelazia callipaeda) infection in dogs.

L Rossi1, C Rigano, E Tomio, D Frassetto, E Ferroglio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18083983

Source DB:  PubMed          Journal:  Vet Rec        ISSN： 0042-4900            Impact factor:   2.695


× No keyword cloud information.
  3 in total

1.  Therapeutic efficacy of milbemycin oxime/praziquantel oral formulation (Milbemax®) against Thelazia callipaeda in naturally infested dogs and cats.

Authors:  Bruna Motta; Manuela Schnyder; Fabrizio Solari Basano; Fabio Nägeli; Catherine Nägeli; Brigitte Schiessl; Egidio Mallia; Riccardo P Lia; Filipe Dantas-Torres; Domenico Otranto
Journal:  Parasit Vectors       Date:  2012-05-19       Impact factor: 3.876

2.  Comparative evaluation of the prophylactic activity of a slow-release insecticide collar and a moxidectin spot-on formulation against Thelazia callipaeda infection in naturally exposed dogs in France.

Authors:  Charlotte Lechat; Noémie Siméon; Olivier Pennant; Loïc Desquilbet; Sabine Chahory; Christophe Le Sueur; Jacques Guillot
Journal:  Parasit Vectors       Date:  2015-02-10       Impact factor: 3.876

Review 3.  Vector-borne helminths of dogs and humans in Europe.

Authors:  Domenico Otranto; Filipe Dantas-Torres; Emanuele Brianti; Donato Traversa; Dusan Petrić; Claudio Genchi; Gioia Capelli
Journal:  Parasit Vectors       Date:  2013-01-16       Impact factor: 3.876
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.